Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2017-11-16 Report Publication Anno…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2017 bis zum 30.09.2017
Report Publication Announcement Classification · 100% confidence The document is a short notification (811 characters) announcing the availability of a quarterly report (Zwischenmitteilung) for the period 01.01.2017 to 30.09.2017. It provides a link to the website where the report can be found and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2017-11-16 German
Datum:16.11.2017
Report Publication Announcement Classification · 100% confidence The document is a short notification (788 characters) announcing the availability of an interim management report for the period 01.01.2017 to 30.09.2017. It provides a link to the website where the report can be found and specifies the publication date. Per the 'Menu vs Meal' rule, since this is a short announcement regarding the publication of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2017-11-16 German
Vita 34 and Berlin Charite launch joint research project
Regulatory Filings Classification · 99% confidence The document is a press release titled "Vita 34 and Berlin Charité launch joint research project" disseminated via DGAP-News. It announces a new study, provides details about the collaboration, and includes contact information for Investor Relations. This type of announcement, detailing a specific corporate event (a research alliance) that is not a standard financial report (like 10-K, ER, or IR), a management change (MANG), or a transaction (POS/CAP), fits best under the general category for corporate news announcements that don't fit elsewhere, which is Regulatory Filings (RNS), as it is disseminated through a regulatory news service (DGAP). It is not a Call Transcript (CT), Earnings Release (ER), or a formal financial report (10-K, IR).
2017-10-25 English
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Frank Köhler), their position ('Member of the administrative or supervisory body'), the nature of the transaction ('Acquisition'), the financial instrument (Share), and the price/volume. This content directly matches the definition for Director's Dealing.
2017-09-14 English
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of a member of the managing body (Dr. Wolfgang Knirsch), the nature of the transaction ('Acquisition'), the financial instrument (Share), and the price/volume. This content directly matches the definition for Director's Dealing.
2017-09-08 English
Vita 34 completes Management Board with the return of Falk Neukirch
Board/Management Information Classification · 100% confidence The document is a short news release dated September 8, 2017, announcing a specific personnel change: the return of Falk Neukirch as CFO to the Management Board of Vita 34 AG. The key phrases are 'Change of Personnel', 'Vita 34 completes Management Board with the return of Falk Neukirch', and the announcement of the new CFO taking over on September 11. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2017-09-08 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.